Search

Maris R. Kessel

Examiner (ID: 14775, Phone: (571)270-7698 , Office: P/1759 )

Most Active Art Unit
1759
Art Unit(s)
1795, 1759, 1758, 1699
Total Applications
485
Issued Applications
239
Pending Applications
11
Abandoned Applications
232

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18784710 [patent_doc_number] => 20230372317 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-23 [patent_title] => A LIQUID INJECTABLE COMPOSITION OF DONEPEZIL [patent_app_type] => utility [patent_app_number] => 18/247943 [patent_app_country] => US [patent_app_date] => 2021-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10199 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18247943 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/247943
A LIQUID INJECTABLE COMPOSITION OF DONEPEZIL Oct 24, 2021 Pending
Array ( [id] => 17546596 [patent_doc_number] => 20220117937 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-04-21 [patent_title] => USE OF SMALL MOLECULE INHIBITORS OF THE BFRB:BFD INTERACTION IN BIOFILMS [patent_app_type] => utility [patent_app_number] => 17/502975 [patent_app_country] => US [patent_app_date] => 2021-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25556 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17502975 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/502975
Use of small molecule inhibitors of the BfrB:Bfd interaction in biofilms Oct 14, 2021 Issued
Array ( [id] => 18815970 [patent_doc_number] => 20230390309 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-12-07 [patent_title] => TETRACYCLINE DERIVATIVES FOR TREATING NEURODEGENERATIVE OR NEUROINFLAMMATORY DISEASES [patent_app_type] => utility [patent_app_number] => 18/031632 [patent_app_country] => US [patent_app_date] => 2021-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6569 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18031632 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/031632
TETRACYCLINE DERIVATIVES FOR TREATING NEURODEGENERATIVE OR NEUROINFLAMMATORY DISEASES Oct 13, 2021 Pending
Array ( [id] => 18852679 [patent_doc_number] => 11850231 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2023-12-26 [patent_title] => Trytophan metabolic stimulation compositions [patent_app_type] => utility [patent_app_number] => 17/500070 [patent_app_country] => US [patent_app_date] => 2021-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3618 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 158 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17500070 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/500070
Trytophan metabolic stimulation compositions Oct 12, 2021 Issued
Array ( [id] => 18817447 [patent_doc_number] => 20230391787 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-12-07 [patent_title] => ORGANIC MOLECULE LIGHT EMITTERS [patent_app_type] => utility [patent_app_number] => 18/030634 [patent_app_country] => US [patent_app_date] => 2021-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17485 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -39 [patent_words_short_claim] => 582 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18030634 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/030634
ORGANIC MOLECULE LIGHT EMITTERS Oct 7, 2021 Pending
Array ( [id] => 17533611 [patent_doc_number] => 20220112220 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-04-14 [patent_title] => FORMULATION OF A PAN-JAK INHIBITOR [patent_app_type] => utility [patent_app_number] => 17/450205 [patent_app_country] => US [patent_app_date] => 2021-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18188 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17450205 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/450205
Formulation of a pan-JAK inhibitor Oct 6, 2021 Issued
Array ( [id] => 18786041 [patent_doc_number] => 20230373997 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-23 [patent_title] => IMDQ-PEG-CHOL ADJUVANT AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 18/030302 [patent_app_country] => US [patent_app_date] => 2021-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 52464 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -93 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18030302 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/030302
IMDQ-PEG-CHOL ADJUVANT AND USES THEREOF Oct 6, 2021 Pending
Array ( [id] => 18808544 [patent_doc_number] => 20230382878 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-30 [patent_title] => A METHOD FOR INCREASING PROPYLENE OXIDE OUTPUT OF AN INTEGRATED PROCESS FOR MAKING PROPYLENE OXIDE AND PROPYLENE GLYCOL [patent_app_type] => utility [patent_app_number] => 18/249584 [patent_app_country] => US [patent_app_date] => 2021-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5012 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18249584 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/249584
A METHOD FOR INCREASING PROPYLENE OXIDE OUTPUT OF AN INTEGRATED PROCESS FOR MAKING PROPYLENE OXIDE AND PROPYLENE GLYCOL Oct 6, 2021 Pending
Array ( [id] => 17851829 [patent_doc_number] => 20220281871 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-08 [patent_title] => Pyrazolo[1,5-A][1,3,5]Triazine and Pyrazolo[1,5-A]Pyrimidine Derivatives as CDK Inhibitors [patent_app_type] => utility [patent_app_number] => 17/492282 [patent_app_country] => US [patent_app_date] => 2021-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32026 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17492282 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/492282
Pyrazolo[1,5-A][1,3,5]Triazine and Pyrazolo[1,5-A]Pyrimidine Derivatives as CDK Inhibitors Sep 30, 2021 Abandoned
Array ( [id] => 17356722 [patent_doc_number] => 20220017518 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-20 [patent_title] => Histone Deacetylase Inhibitors and Methods of Use Thereof [patent_app_type] => utility [patent_app_number] => 17/487279 [patent_app_country] => US [patent_app_date] => 2021-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23005 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17487279 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/487279
Histone Deacetylase Inhibitors and Methods of Use Thereof Sep 27, 2021 Abandoned
Array ( [id] => 17480480 [patent_doc_number] => 20220087984 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-24 [patent_title] => USE OF TACROLIMUS IN PREPARATION OF MEDICAMENT FOR INITIATING TISSUE REGENERATION FUNCTION [patent_app_type] => utility [patent_app_number] => 17/479869 [patent_app_country] => US [patent_app_date] => 2021-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1658 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17479869 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/479869
Use of tacrolimus in preparation of medicament for initiating tissue regeneration function Sep 19, 2021 Issued
Array ( [id] => 18753919 [patent_doc_number] => 20230357261 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-09 [patent_title] => ARYL HYDROCARBON RECEPTOR LIGANDS AND THEIR ANALOGUES FOR THE PREVENTION AND TREATMENT OF INFLAMMATORY DISORDERS [patent_app_type] => utility [patent_app_number] => 18/025797 [patent_app_country] => US [patent_app_date] => 2021-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34591 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -36 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18025797 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/025797
ARYL HYDROCARBON RECEPTOR LIGANDS AND THEIR ANALOGUES FOR THE PREVENTION AND TREATMENT OF INFLAMMATORY DISORDERS Sep 16, 2021 Pending
Array ( [id] => 19201397 [patent_doc_number] => 20240173296 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-05-30 [patent_title] => PHARMACEUTICAL COMPOSITION OF (S)-KETOROLAC AND PREPARATION METHOD THEREFOR [patent_app_type] => utility [patent_app_number] => 17/776428 [patent_app_country] => US [patent_app_date] => 2021-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14219 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17776428 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/776428
PHARMACEUTICAL COMPOSITION OF (S)-KETOROLAC AND PREPARATION METHOD THEREFOR Sep 16, 2021 Pending
Array ( [id] => 18768637 [patent_doc_number] => 20230363391 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-16 [patent_title] => Biocidal Composition and Method [patent_app_type] => utility [patent_app_number] => 18/026204 [patent_app_country] => US [patent_app_date] => 2021-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6542 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18026204 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/026204
Biocidal Composition and Method Sep 13, 2021 Pending
Array ( [id] => 18287599 [patent_doc_number] => 20230103071 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-30 [patent_title] => METHOD FOR PURIFICATION OF TERPENOID AMINO ALCOHOL DERIVATIVES [patent_app_type] => utility [patent_app_number] => 17/467974 [patent_app_country] => US [patent_app_date] => 2021-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2851 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 103 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17467974 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/467974
Method for purification of terpenoid amino alcohol derivatives Sep 6, 2021 Issued
Array ( [id] => 19871328 [patent_doc_number] => 12264172 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-04-01 [patent_title] => Phosphonate products and methods [patent_app_type] => utility [patent_app_number] => 18/043987 [patent_app_country] => US [patent_app_date] => 2021-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 8 [patent_no_of_words] => 28507 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 155 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18043987 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/043987
Phosphonate products and methods Sep 1, 2021 Issued
Array ( [id] => 18726018 [patent_doc_number] => 20230340270 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-26 [patent_title] => CYANINE COMPOUND AND PHOTOELECTRIC CONVERSION ELEMENT [patent_app_type] => utility [patent_app_number] => 18/026687 [patent_app_country] => US [patent_app_date] => 2021-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15492 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 209 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18026687 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/026687
CYANINE COMPOUND AND PHOTOELECTRIC CONVERSION ELEMENT Aug 31, 2021 Pending
Array ( [id] => 17299393 [patent_doc_number] => 20210395232 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-23 [patent_title] => CO-CRYSTAL FORMS OF SELINEXOR [patent_app_type] => utility [patent_app_number] => 17/446664 [patent_app_country] => US [patent_app_date] => 2021-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4528 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 4 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17446664 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/446664
CO-CRYSTAL FORMS OF SELINEXOR Aug 31, 2021 Pending
Array ( [id] => 20329680 [patent_doc_number] => 12459945 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-11-04 [patent_title] => Use of caseinolytic protease P function as a biomarker of drug response to imipridone-like agents [patent_app_type] => utility [patent_app_number] => 17/459960 [patent_app_country] => US [patent_app_date] => 2021-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 12 [patent_no_of_words] => 26731 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17459960 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/459960
Use of caseinolytic protease P function as a biomarker of drug response to imipridone-like agents Aug 26, 2021 Issued
Array ( [id] => 18496442 [patent_doc_number] => 20230219015 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-07-13 [patent_title] => EXTRACTION METHOD AND MIXTURE OF SUBSTANCES [patent_app_type] => utility [patent_app_number] => 18/022869 [patent_app_country] => US [patent_app_date] => 2021-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2998 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -29 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18022869 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/022869
EXTRACTION METHOD AND MIXTURE OF SUBSTANCES Aug 25, 2021 Pending
Menu